Drug Trial Radar · NCT07533006
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
65
Planned (sponsor's estimate)
Start
Apr 14, 2026
Primary completion
Jun 2027
Study completion Oct 2027
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Apr 16, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate how well LY4005130 works in participants with severe alopecia areata (hair loss) when compared with placebo, and how well it's tolerated and what side effects may occur. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. The study drug will be administered intravenously (IV) (into a vein in the arm). The study will last approximately 48 weeks, including screening.
Conditions
- Alopecia Areata
Interventions
LY4005130Drug
Administered IV
PlaceboDrug
Administered IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving an Absolute Severity of Alopecia Tool (SALT) Less than or Equal to (≤) 20Time frame: Week 24
Locations
30 sites in 7 countries. Site status is shown where the registry gives one.
Center For Dermatology Clinical Research, Inc.
Fremont, California · Recruiting
Northridge Clinical Trials
Northridge, California · Recruiting
Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway
Santa Clarita, California · Recruiting
Health Clinical Research, LLC
Cutler Bay, Florida · Recruiting
Brigham and Women's Hospital
Boston, Massachusetts · Recruiting
Revival Research Institute, LLC
Troy, Michigan · Recruiting
Stracskin
Portsmouth, New Hampshire · Recruiting
Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue
San Antonio, Texas · Recruiting
Jordan Valley Dermatology & Research Center
South Jordan, Utah · Recruiting
Kelowna Health and Memory Centre
Kelowna, Canada · Recruiting
Ryan Clinical Research Inc.
Newmarket, Canada · Recruiting
Dar Clinical Research - Ottawa - Hunt Club Road
Ottawa, Canada · Recruiting
SIMa Recherche
Verdun, Canada · Recruiting
Beijing Friendship Hospital Affiliate of Capital University
Beijing, China · Recruiting
Huashan Hospital, Fudan University
Shanghai, China · Recruiting
Shanghai Skin Disease Hospital
Shanghai, China · Recruiting
Tianjin Medical University General Hospital
Tianjin, China · Recruiting
Erasmus Medisch Centrum
Rotterdam, Netherlands · Recruiting
Centrum Badan Klinicznych PI-House sp. z o.o.
Gdansk, Poland · Recruiting
Diamond Clinic
Krakow, Poland · Recruiting
Dermedic Jacek Zdybski
Ostrowiec Świętokrzyski, Poland · Recruiting
Centrum Medyczne Ginemedica
Wroclaw, Poland · Recruiting
Chung-Ang University Hospital
Dongjak-gu, South Korea · Recruiting
Inha University Hospital
Incheon, South Korea · Recruiting
Jeonbuk National University Hospital
Jeonju, South Korea · Recruiting
Seoul National University Hospital
Seoul, South Korea · Recruiting
Kyung Hee University Hospital at Gangdong
Seoul, South Korea · Recruiting
Royal London Hospital
London, United Kingdom · Recruiting
Chelsea and Westminster Hospital NHS Foundation Trust
London, United Kingdom · Recruiting
Salford Royal Hospital
Salford, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.